Comments

OS Therapies Stock Price, Quotes and Forecasts

Q: What sector and industry does OS Therapies (OSTX) operate in?

OS Therapies is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

OSTXAMEX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.60

-0.03-1.84%

At close: -

OS Therapies (OSTX) Forecast

News Earnings OS Therapies (OSTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

OS Therapies Stock Price, Quotes and Forecasts | AMEX:OSTX | Benzinga

Explore OS Therapies stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OSTX.

Open	$1.59
Close	$1.60
Volume / Avg.	108.73K / 1.20M
Day Range	$1.50 - $1.62
52 Wk Range	1.41 - 7.00
Market Cap	$33.98M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	39
Short Interest	3.45%
Days to Cover	1.66

Recent News

Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer

OS Therapies advances OST-HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.

Vandana Singh

Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday?

OS Therapies shares Phase 2b trial results showing OST-HER2 improves survival rates in rare metastatic osteosarcoma, surpassing historical controls.

Vandana Singh

Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.59
Close	$1.60
Volume / Avg.	108.73K / 1.20M
Day Range	$1.50 - $1.62
52 Wk Range	1.41 - 7.00
Market Cap	$33.98M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	39
Short Interest	3.45%
Days to Cover	1.66

About OS Therapies Inc

Sector

Health Care

Industry

Biotechnology

OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy OS Therapies (OSTX) stock?

You can purchase shares of OS Therapies (AMEX:OSTX) through any online brokerage.

View our list of the best stock brokerages

Who are OS Therapies (OSTX) competitors?

Other companies in OS Therapies’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Intensity Therapeutics (NASDAQ:INTS), Coeptis Therapeutics (NASDAQ:COEP), CollPlant Biotechnologies (NASDAQ:CLGN) and FibroBiologics (NASDAQ:FBLG).

What is the forecast, or price target, for OS Therapies (OSTX) stock?

OS Therapies has a consensus price target of $18.67.

What is the current price for OS Therapies (OSTX)?

The stock price for OS Therapies (AMEX: OSTX) is $1.62 last updated March 18, 2025 at 8:52 AM EDT.

Does OS Therapies (OSTX) pay a dividend?

There are no upcoming dividends for OS Therapies.

When is OS Therapies (AMEX:OSTX) reporting earnings?

OS Therapies’s Q1 earnings are confirmed for Thursday, May 15, 2025.

Is OS Therapies (OSTX) going to split?

There is no upcoming split for OS Therapies.

What sector and industry does OS Therapies (OSTX) operate in?

OS Therapies is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.